Irreversible end-stage cardiomyopathy following a single dose of cyclophosphamide

Congest Heart Fail. 2012 Jul-Aug;18(4):234-7. doi: 10.1111/j.1751-7133.2011.00279.x. Epub 2012 Jan 9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cardiomyopathies / chemically induced*
  • Cyclophosphamide / adverse effects*
  • Female
  • Glomerulonephritis
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Middle Aged

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide